clinicaltrials.gov/ct2/show...
New clinical trial registered: InSightec has registered a two-arm, open-label study to establish safety & feasibility of intracerebral delivery of GCase (via MR-guided focused ultrasound) in 14 individuals with Parkinsons (7 GBA-PD & 7 iPD)
Official Title: A Phase I/II Study for Bilateral Putamenal Delivery of Recombinant Glucocerebrosidase in Patients With Parkinson's Disease Using MR-guided Focused Ultrasound Induced Opening of the Blood-brain Barrier
Estimated Study Completion Date: December 31, 2023
Phase 4 study to evaluate efficacy of orally administrated Trehalose in individuals with idiopathic & LRRK2-associated Parkinsons
Has anyone investigated or had a focused ultrasound procedure done. I would like first-hand information, as I am looking into it for John. 
Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2020
Getting Closer in Switzerland from Dr. Gallay.... Phase 3, the Lighthouse study, Biogen and Denali, LRRK2 inhibitor BIIB122; New clinical trial registered
